In the month ending April 7, 423 cancer patients at Memorial Sloan Kettering Cancer Center were diagnosed with COVID-19, 20% of whom developed severe respiratory symptoms. That in itself was not surprising, given that cancer patients are immunocompromised and therefore face an increased risk of fighting the virus. But a …
Read More »Bristol-Myers Squibb Cancer Drug Pipeline Could Lead Sales of $ 20 Billion
Text size Bristol-Myers Squibb is telling analysts this week that its portfolio of developing drugs could generate more sales than anyone expected. In a series of online meetings that started Monday, the drug maker raised its forecast for annual sales it could get from advanced-stage candidates from $ 15 billion …
Read More »